Assessing Tobacco Product Choice When the Cost of Menthol Cigarettes Increases
Status: | Recruiting |
---|---|
Conditions: | Smoking Cessation, Smoking Cessation |
Therapuetic Areas: | Pulmonary / Respiratory Diseases |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 9/30/2018 |
Start Date: | July 9, 2018 |
End Date: | February 2020 |
Contact: | Rachel Denlinger, MPH |
Email: | rachel_denlinger@brown.edu |
Phone: | 401-262-0316 |
In this study, participants will complete a behavioral economics laboratory task and
validation field assessments to understand how menthol cigarette policy restrictions may
affect tobacco product purchasing and use.
validation field assessments to understand how menthol cigarette policy restrictions may
affect tobacco product purchasing and use.
We will enroll 60 smokers who will complete four lab sessions and two field assessments.
Participants meeting initial eligibility criteria over the phone will complete an in-person
screening visit. Breath carbon monoxide and alcohol tests will be collected. Participants
will answer questionnaires on the computer and via interview about their tobacco use and
medical history. Eligible participants will remain in the lab to complete additional baseline
questionnaires and will be given the opportunity to sample alternative tobacco products, such
as LCCs, smokeless tobacco, electronic cigarettes, and nicotine replacement.
During the next two lab sessions, participants will complete a behavioral economics
assessment, the Experimental Tobacco Marketplace task, designed to simulate purchasing
tobacco products online. Participants will be given 'coupons' to obtain tobacco products from
the online experimental marketplace. After these lab sessions, participants will be provided
with the tobacco products they selected from the online experimental marketplace to use
during 3-day field assessments to validate the task. Participants will be told to only use
tobacco products provided by the lab during the field assessments. At both lab sessions,
participants will complete questionnaires about their tobacco use, mood, and reactions to the
alternative tobacco products. At the final lab session, a qualitative interview will be
conducted to learn more about the participants' experiences selecting and using tobacco
products.
Participants meeting initial eligibility criteria over the phone will complete an in-person
screening visit. Breath carbon monoxide and alcohol tests will be collected. Participants
will answer questionnaires on the computer and via interview about their tobacco use and
medical history. Eligible participants will remain in the lab to complete additional baseline
questionnaires and will be given the opportunity to sample alternative tobacco products, such
as LCCs, smokeless tobacco, electronic cigarettes, and nicotine replacement.
During the next two lab sessions, participants will complete a behavioral economics
assessment, the Experimental Tobacco Marketplace task, designed to simulate purchasing
tobacco products online. Participants will be given 'coupons' to obtain tobacco products from
the online experimental marketplace. After these lab sessions, participants will be provided
with the tobacco products they selected from the online experimental marketplace to use
during 3-day field assessments to validate the task. Participants will be told to only use
tobacco products provided by the lab during the field assessments. At both lab sessions,
participants will complete questionnaires about their tobacco use, mood, and reactions to the
alternative tobacco products. At the final lab session, a qualitative interview will be
conducted to learn more about the participants' experiences selecting and using tobacco
products.
Inclusion Criteria:
1. Ages 18 and older
2. Daily smokers who smoke on average at least 5 cigarettes per day for the past 12
months
3. Self-report smoking a menthol cigarette brand
4. Must report use of an alternative tobacco product(s) at least once in the past month
5. Breath CO levels > 8 ppm (if < 8 ppm, then NicAlert Strip = 6)
6. Speak, comprehend, and read English well enough to complete study procedures
Exclusion Criteria:
1. Breath alcohol level > 0.01 ng/ml
2. Intention to quit smoking in the next 30 days
3. Self-reported serious medical or psychiatric conditions during the past 12 months
including:
1. heart attack
2. stroke
3. angina
4. blood clots in the arms or legs for which the individual is undergoing active
medical treatment
5. cancer requiring active chemotherapy or radiation therapy
6. chronic obstructive pulmonary disease
7. schizophrenia
4. Pregnant or breastfeeding
5. CO reading > 80 ppm
6. Enrollment stratum (white or African-American/black) is full
We found this trial at
1
site
Providence, Rhode Island 02912
Principal Investigator: Rachel Denlinger, MPH
Click here to add this to my saved trials
